Mon. 4 Mar 2024, 12:35pm ET
Benzinga
Biotech, News, General
RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"
Company Profile